This newsletter activity highlights some of the new concepts reshaping the approaches to Parkinson's Disease (PD) that were presented at a recent national meeting of neurologists in Washington, DC. Guest editor Kapil D. Sethi, MD, FRCP, professor of neurology and director of the Movement Disorders Program at Georgia Regents University in Augusta, Georgia, guides insights into presentations exploring the role of alpha synuclein in the formation of Lewy bodies associated with motor deficits in PD. Investigations into alpha synuclein targets for disease interventions, new models for research, and a restructured approach to diagnosing neurodegenerative diseases according to 'proteinopathy' are all examined.

Faculty

  Kapil D. Sethi, MD, FRCP
  Professor of Neurology
  Director, Movement Disorders Program
  Georgia Regents University
  Augusta, Georgia

Target audience

This activity was developed for neurologists and Parkinson's disease specialists including nurses, nurse practitioners and physician assistants. This activity will also be of interest to primary care physicians and other health care professionals who care for patients with PD. 

Learning Objectives

At the conclusion of this activity, participants should be better able to:

• Interpret emerging Parkinson's data for its applicability to clinical practice
• Integrate results from newly published data into Parkinson's disease management

Instructions

You may participate by reading the newsletter and completing the post test questions. When ready to claim your CME credit, click on and complete the "Program Evaluation" first (required) and then click on "Certificate" to receive your certificate.

This activity is supported by an independent educational grant from AbbVie, Inc.